Related Experiment Video
Updated: Aug 4, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Acquired Hemophilia A: A Case Report on a Rare Disease Manifesting as Persistent Hematuria
Amber Kuta1, Karina S Shendrik1, Linda Youn1
1Department of Internal Medicine, St. Bernards Medical Center, Jonesboro, USA.
Abstract:
Hemophilia A is most commonly a genetic clotting disorder that is caused by a decrease or lack of activity of clotting factor VIII. Acquired hemophilia, a rarer subset can occur later on in life. The incidence rate of the latter subtype is estimated to affect one per million cases a year. Given the rarity of the disease, the associated hemoglobin and hematocrit reduction seen from this can easily be missed and attributed to concomitant disorders such as hematuria. Our patient initially presented with persistent hematuria, was treated with multiple rounds of antibiotics, and underwent a plethora of urological studies with no resolution or explanation of her symptoms. It wasn't until her ICU admission that coagulation studies were reviewed in depth and workup for hemophilia A began. The American Urologic Association's hematuria workup is currently limited to the genitourinary system with no consideration for hematological disorders. We believe that the medical community may benefit from further research in this area in order to avoid mismanaging patients medically and thus minimize morbidity and mortality.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Venous Thrombosis IV: Nursing Management

